• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人鼻病毒14中抑制脱壳的抗病毒药物的附着位点。

The site of attachment in human rhinovirus 14 for antiviral agents that inhibit uncoating.

作者信息

Smith T J, Kremer M J, Luo M, Vriend G, Arnold E, Kamer G, Rossmann M G, McKinlay M A, Diana G D, Otto M J

出版信息

Science. 1986 Sep 19;233(4770):1286-93. doi: 10.1126/science.3018924.

DOI:10.1126/science.3018924
PMID:3018924
Abstract

WIN 51711 and WIN 52084 are structurally related, antiviral compounds that inhibit the replication of rhino (common cold) viruses and related picornaviruses. They prevent the pH-mediated uncoating of the viral RNA. The compounds consist of a 3-methylisoxazole group that inserts itself into the hydrophobic interior of the VP1 beta-barrel, a connecting seven-membered aliphatic chain, and a 4-oxazolinylphenoxy group (OP) that covers the entrance to an ion channel in the floor of the "canyon." Viral disassembly may be inhibited by preventing the collapse of the VP1 hydrophobic pocket or by blocking the flow of ions into the virus interior.

摘要

WIN 51711和WIN 52084是结构相关的抗病毒化合物,可抑制鼻病毒(普通感冒病毒)及相关微小核糖核酸病毒的复制。它们可阻止pH介导的病毒RNA脱壳。这些化合物由一个插入VP1β桶疏水内部的3-甲基异恶唑基团、一条连接的七元脂肪链以及一个覆盖“峡谷”底部离子通道入口的4-恶唑啉基苯氧基(OP)组成。病毒解体可能通过阻止VP1疏水口袋的塌陷或通过阻断离子流入病毒内部而受到抑制。

相似文献

1
The site of attachment in human rhinovirus 14 for antiviral agents that inhibit uncoating.人鼻病毒14中抑制脱壳的抗病毒药物的附着位点。
Science. 1986 Sep 19;233(4770):1286-93. doi: 10.1126/science.3018924.
2
Prevention of rhinovirus and poliovirus uncoating by WIN 51711, a new antiviral drug.新型抗病毒药物WIN 51711对鼻病毒和脊髓灰质炎病毒脱壳的预防作用
Antimicrob Agents Chemother. 1986 Jul;30(1):110-6. doi: 10.1128/AAC.30.1.110.
3
Structural studies on human rhinovirus 14 drug-resistant compensation mutants.人鼻病毒14耐药补偿突变体的结构研究
J Mol Biol. 1995 Oct 13;253(1):61-73. doi: 10.1006/jmbi.1995.0536.
4
SDZ 35-682, a new picornavirus capsid-binding agent with potent antiviral activity.SDZ 35-682,一种具有强大抗病毒活性的新型微小核糖核酸病毒衣壳结合剂。
Antiviral Res. 1995 Jan;26(1):65-82. doi: 10.1016/0166-3542(94)00066-h.
5
A novel basis of capsid stabilization by antiviral compounds.抗病毒化合物稳定衣壳的新机制。
J Mol Biol. 1995 Dec 8;254(4):544-51. doi: 10.1006/jmbi.1995.0637.
6
Structural analysis of antiviral agents that interact with the capsid of human rhinoviruses.与人类鼻病毒衣壳相互作用的抗病毒药物的结构分析。
Proteins. 1989;6(1):1-19. doi: 10.1002/prot.340060102.
7
SCH 38057: a picornavirus capsid-binding molecule with antiviral activity after the initial stage of viral uncoating.SCH 38057:一种在病毒脱壳初始阶段后具有抗病毒活性的小核糖核酸病毒衣壳结合分子。
Antiviral Res. 1993 May;21(1):15-35. doi: 10.1016/0166-3542(93)90064-p.
8
Structural analysis of a series of antiviral agents complexed with human rhinovirus 14.一系列与人类鼻病毒14复合的抗病毒药物的结构分析
Proc Natl Acad Sci U S A. 1988 May;85(10):3304-8. doi: 10.1073/pnas.85.10.3304.
9
CoMFA analysis of the interactions of antipicornavirus compounds in the binding pocket of human rhinovirus-14.人鼻病毒-14结合口袋中抗微小核糖核酸病毒化合物相互作用的比较分子场分析。
J Med Chem. 1992 Mar 20;35(6):1002-8. doi: 10.1021/jm00084a005.
10
WIN 52035-2 inhibits both attachment and eclipse of human rhinovirus 14.WIN 52035-2可抑制人鼻病毒14的吸附及隐蔽期。
J Virol. 1993 Apr;67(4):2245-54. doi: 10.1128/JVI.67.4.2245-2254.1993.

引用本文的文献

1
Structural insights from vaccine candidates for EV-D68.肠道病毒D68疫苗候选物的结构见解
Commun Biol. 2025 Jun 4;8(1):860. doi: 10.1038/s42003-025-08253-y.
2
Heterogeneous Condensation on Simplified Viral Envelope Protein Structures.简化病毒包膜蛋白结构上的异质凝聚
ACS Appl Mater Interfaces. 2025 May 14;17(19):27829-27838. doi: 10.1021/acsami.5c01789. Epub 2025 May 3.
3
In Vitro Model to Test Therapeutic Agents Against Rhinovirus Infection.用于测试抗鼻病毒感染治疗药物的体外模型
Methods Mol Biol. 2025;2903:185-191. doi: 10.1007/978-1-0716-4410-2_15.
4
DMSO might impact ligand binding, capsid stability, and RNA interaction in viral preparations.二甲基亚砜可能会影响病毒制剂中的配体结合、衣壳稳定性和RNA相互作用。
Sci Rep. 2024 Dec 6;14(1):30408. doi: 10.1038/s41598-024-81789-x.
5
Endosome rupture enables enteroviruses from the family Picornaviridae to infect cells.内体破裂使小核糖核酸病毒科的肠道病毒能够感染细胞。
Commun Biol. 2024 Nov 8;7(1):1465. doi: 10.1038/s42003-024-07147-9.
6
The Structural Framework and Opening Appearance of the VP1-Pocket of Enteroviruses Correlated with Viral Thermostability.肠道病毒VP1口袋的结构框架与开放外观及其与病毒热稳定性的相关性
Pathogens. 2024 Aug 22;13(8):711. doi: 10.3390/pathogens13080711.
7
Identification of epidermal growth factor receptor-tyrosine kinase inhibitor targeting the VP1 pocket of human rhinovirus.鉴定靶向人鼻病毒 VP1 口袋的表皮生长因子受体酪氨酸激酶抑制剂。
Antimicrob Agents Chemother. 2024 Mar 6;68(3):e0106423. doi: 10.1128/aac.01064-23. Epub 2024 Feb 13.
8
Cathelicidin peptide analogues inhibit EV71 infection through blocking viral entry and uncoating.cathelicidin肽类似物通过阻断病毒进入和脱壳来抑制肠道病毒71型(EV71)感染。
PLoS Pathog. 2024 Jan 25;20(1):e1011967. doi: 10.1371/journal.ppat.1011967. eCollection 2024 Jan.
9
Design Rules for the Sequestration of Viruses into Polypeptide Complex Coacervates.将病毒隔离到多肽复合凝聚层中的设计规则
Biomacromolecules. 2024 Feb 12;25(2):741-753. doi: 10.1021/acs.biomac.3c00938. Epub 2023 Dec 16.
10
A human monoclonal antibody binds within the poliovirus receptor-binding site to neutralize all three serotypes.一种人源单克隆抗体与脊髓灰质炎病毒受体结合位点结合,从而中和所有三个血清型。
Nat Commun. 2023 Oct 10;14(1):6335. doi: 10.1038/s41467-023-41052-9.